Stelo is a small, wearable sensor worn on the back of the upper arm. It delivers glucose readings 24/7 directly to a smartphone,†revealing powerful, personalized insights about glucose health. Be the first to know Get started today with Dexcom G7. ...
INDICATIONS FOR USE: The Stelo Glucose Biosensor System is an over-the-counter (OTC) integrated Continuous Glucose Monitor (iCGM) intended to continuously measure, record, analyze, and display glucose values in people 18 years and older not on insulin. The Stelo Glucose Biosensor System helps to...
Stelo is the first over the counter (OTC) wearable glucose biosensor available without a prescription, suitable for people with type 2 diabetes not on insulin.
INDICATIONS FOR USE: The Stelo Glucose Biosensor System is an over-the-counter (OTC) integrated Continuous Glucose Monitor (iCGM) intended to continuously measure, record, analyze, and display glucose values in people 18 years and older not on insulin. The Stelo Glucose Biosensor System helps to...
INDICATIONS FOR USE: The Stelo Glucose Biosensor System is an over-the-counter (OTC) integrated Continuous Glucose Monitor (iCGM) intended to continuously measure, record, analyze, and display glucose values in people 18 years and older not on insulin. The Stelo Glucose Biosensor System helps to...
INDICATIONS FOR USE: The Stelo Glucose Biosensor System is an over-the-counter (OTC) integrated Continuous Glucose Monitor (iCGM) intended to continuously measure, record, analyze, and display glucose values in people 18 years and older not on insulin. The Stelo Glucose Biosensor System helps to...
INDICATIONS FOR USE: The Stelo Glucose Biosensor System is an over-the-counter (OTC) integrated Continuous Glucose Monitor (iCGM) intended to continuously measure, record, analyze, and display glucose values in people 18 years and older not on insulin. The Stelo Glucose Biosensor System helps to...
INDICATIONS FOR USE: The Stelo Glucose Biosensor System is an over-the-counter (OTC) integrated Continuous Glucose Monitor (iCGM) intended to continuously measure, record, analyze, and display glucose values in people 18 years and older not on insulin. The Stelo Glucose Biosensor System helps to...
8月26日,Dexcom宣布推出Stelo,这是美国首款无需处方即可购买的连续血糖监测仪 (CGM)。 该设备已于3月获得 FDA 审批,可用于未接受胰岛素治疗且没有问题性低血糖症(低血糖)的 18 岁及以上人群。 Dexcom 执行副总裁兼首席运营官 Jake Leach 表示:“25 年来,Dexcom 一直处于葡萄糖生物传感领域的前沿。随着 Stelo...
Stelo CGM是一种连续血糖监测仪，旨在满足2型糖尿病患者的特殊需求。与1型糖尿病患者不同，2型糖尿病患者通常不需要使用胰岛素治疗，而是通过口服药物来控制血糖水平。然而，传统的CGM设备通常不适用于这一患者群体。Stelo CGM的推出填补了这一市场空缺，为2型糖尿病患者提供了实时查看血糖水平的便捷方式。Stelo CGM...